Papers: 14 Mar 2014 - 21 Mar 2014 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients. Mameli G, Cossu D, Cocco E, Masala S, Frau J, Marrosu M G, Sechi LA J Neuroimmunol. 2014 Mar 6. Epub 1969 Dec 31. PMID: 24642384. Abstract Editors' Pick Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis. Bible E Nat Rev Neurol. 2014 Apr; 10(4):182. Epub 2014 Mar 18. PMID: 24638130. Abstract Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: A case report. Piola M, Di Palma F, Mascoli N, Binda S, Arnaboldi M, Rezzonico M J Neurol Sci. 2014 Mar 5. PMID: 24642511. Abstract Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs. Lu E, Zhu F, Zhao Y, van der Kop M, Synnes A, Dahlgren L, Sadovnick DA, Traboulsee A, Tremlett H CNS Drugs. 2014 Mar 19. PMID: 24643915. Abstract Significant increase in the prevalence of multiple sclerosis in iran in 2011. Izadi S, Nikseresht A, Sharifian M, Sahraian M A, Hamidian Jahromi A, Aghighi M, Heidary A Iran J Med Sci. 2014 Mar; 39(2):152-3. PMID: 24644387. Abstract Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches. Guo S, Pelligra C, Saint-Laurent Thibault C, Hernandez L, Kansal A Pharmacoeconomics. 2014 Mar 19. PMID: 24643323. Abstract miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation. Liu S-Q, Jiang S, Li C, Zhang B, Li Q-J J Biol Chem. 2014 Mar 18. PMID: 24644282. Abstract Participation of interleukin 17A in neuroimmune interactions. Moynes DM, Vanner SJ, Lomax AE Brain Behav Immun. 2014 Mar 15. PMID: 24642072. Abstract Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase. Sriskantharajah S, Gückel E, Tsakiri N, Kierdorf K, Brender C, Ben-Addi A, Veldhoen M, Tsichlis PN, Stockinger B, O'Garra A, et al. J Immunol. 2014 Mar 17. PMID: 24639351. Abstract Empyema presenting as lower extremity weakness. Saha D, Cepeda J, Hayden D, Ciment A Chest. 2014 Mar 1; 145(3 Suppl):118A. PMID: 24638293. Abstract Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis. Chuluundorj D, Harding SA, Abernethy D, La Flamme A C Immunol Cell Biol. 2014 Mar 18. PMID: 24638064. Abstract Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method. Michel P, Baumstarck K, Boyer L, Fernandez O, Flachenecker P, Pelletier J, Loundou A, Ghattas B, Auquier P, on behalf of the MusiQoL Study Group Med Care. 2014 Mar 15. PMID: 24638117. Abstract Targeting IL-10 in Auto-immune Diseases. Tian G, Li J-L, Wang D-G, Zhou D Cell Biochem Biophys. 2014 Mar 18. PMID: 24639111. Abstract Review: In relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates. Weinshenker BG Ann Intern Med. 2014 Mar 18; 160(6):JC5. PMID: 24638183. Abstract Core outcome measures for exercise studies in people with multiple sclerosis: recommendations from a multidisciplinary consensus meeting. Paul L, Coote S, Crosbie J, Dixon D, Hale L, Holloway E, McCrone P, Miller L, Saxton J, Sincock C, et al. Mult Scler. 2014 Mar 17. PMID: 24639480. Abstract Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis. Sati P, Thomasson D, Li N, Pham D, Biassou N, Reich DS, Butman J Mult Scler. 2014 Mar 17. PMID: 24639479. Abstract Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Narayanan D, Cheng H, Bonem KN, Saenz R, Tang RA, Frishman LJ Mult Scler. 2014 Mar 17. PMID: 24639478. Abstract Transverse Myelitis Associated With an Itchy Rash and HyperCkemia: Neuromyelitis Optica Associated With Dermatitis Herpetiformis. Iyer A, Rathnasabapathi D, Elsone L, Mutch K, Terlizzo M, Footitt D, Jacob A JAMA Neurol. 2014 Mar 17. PMID: 24637913. Abstract Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica. Ratelade J, Smith AJ, Verkman AS Exp Neurol. 2014 Mar 14; 255C:145-153. PMID: 24636863. Abstract Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients. Gresle MM, Liu Y, Dagley LF, Haartsen J, Pearson F, Purcell AW, Laverick L, Petzold A, Lucas R, Van der Walt A, et al. J Neurol Neurosurg Psychiatry. 2014 Mar 17. PMID: 24639436. Abstract Role of SFB in autoimmune arthritis: An example of regulation of autoreactive T cell sensitivity in the gut. Chappert P Gut Microbes. 2014 Feb 6; 5(2). PMID: 24637598. Abstract Diffusion tensor imaging of the cervical spinal cord of patients with Neuromyelitis Optica. Rivero RLM, Oliveira EML, Bichuetti DB, Gabbai AA, Nogueira RG, Abdala N Magn Reson Imaging. 2014 Feb 7. PMID: 24636569. Abstract [Immunomodulatory properties of stem mesenchymal cells in autoimmune diseases.] Sánchez-Berná I, Santiago-Díaz C, Jiménez-Alonso J Med Clin (Barc). 2014 Mar 14. PMID: 24636281. Abstract Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MS. Haghikia A, Gold R Nat Rev Neurol. 2014 Apr; 10(4):183-4. Epub 2014 Mar 18. PMID: 24638132. Abstract Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Friese MA, Schattling B, Fugger L Nat Rev Neurol. 2014 Apr; 10(4):225-38. Epub 2014 Mar 18. PMID: 24638138. Abstract Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis. Lill CM, Schilling M, Ansaloni S, Schröder J, Jaedicke M, Luessi F, Schjeide B-MM, Mashychev A, Graetz C, Akkad DA, et al. Neurogenetics. 2014 Mar 18. Epub 2014 Mar 18. PMID: 24638856. Abstract Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants. Briggs FBS, Acuna B, Shen L, Ramsay P, Quach H, Bernstein A, Bellesis KH, Kockum IS, Hedström AK, Alfredsson L, et al. Epidemiology. 2014 Mar 12. PMID: 24625537. Abstract Thermal and motor behavior in experimental autoimmune encephalitis in Lewis rats. Wrotek S, Rosochowicz T, Nowakowska A, Kozak W Autoimmunity. 2014 Mar 13. PMID: 24625014. Abstract Regulatory T-cell vaccination independent of auto-antigen. Pascual DW, Yang X, Holderness K, Jun S, Maddaloni M, Kochetkova I Exp Mol Med. 2014; 46:e82. PMID: 24626168. Abstract Optical coherence tomography shows retinal abnormalities associated with optic nerve disease. Tawse KL, Hedges TR, Gobuty M, Mendoza-Santiesteban C Br J Ophthalmol. 2014 Mar 13. PMID: 24627251. Abstract DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation. Minten C, Alt C, Gentner M, Frei E, Deutsch U, Lyck R, Schaeren-Wiemers N, Rot A, Engelhardt B Brain. 2014 Mar 12. PMID: 24625696. Abstract Aquaporins: important but elusive drug targets. Verkman AS, Anderson MO, Papadopoulos MC Nat Rev Drug Discov. 2014 Mar 14. PMID: 24625825. Abstract Immunomodulatory agents and risk of postpartum multiple sclerosis relapses. Beaber B E, Chi MD, Brara S M, Zhang J L, Langer-Gould AM Perm J. 2014 Winter; 18(1):9-13. PMID: 24626066. Abstract Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study. Zivadinov R, Dwyer MG, Markovic-Plese S, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Hayward B, Dangond F, et al. PLoS One. 2014; 9(3):e91098. Epub 2014 Mar 13. PMID: 24625687. Abstract Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes. Coyle PK, Cohen BA, Leist T, Markowitz C, Oleen-Burkey M, Schwartz M, Tullman MJ, Zwibel H BMC Neurol. 2014; 14(1):49. Epub 2014 Mar 13. PMID: 24624979. Abstract The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis. Vazirinejad R, Ahmadi Z, Arababadi M K, Hassanshahi G, Kennedy D Neuroimmunomodulation. 2014 Mar 8. Epub 2014 Mar 08. PMID: 24642726. Abstract Antineutrophil Cytoplasmic Antibodies in Patients with Idiopathic Inflammatory-Demyelinating Diseases. Long Y, Zheng Y, Chen M, Zhang B, Gao C, Gao Q, Yin J-R, Pu S, Xie C Neuroimmunomodulation. 2014 Mar 8. Epub 2014 Mar 08. PMID: 24642629. Abstract Chemokines and chemokine receptors in multiple sclerosis. Cheng W, Chen G Mediators Inflamm. 2014; 2014:659206. Epub 2014 Jan 02. PMID: 24639600. Abstract
Editors' Pick Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides are cross recognized by anti-myelin basic protein antibodies in multiple sclerosis patients. Mameli G, Cossu D, Cocco E, Masala S, Frau J, Marrosu M G, Sechi LA J Neuroimmunol. 2014 Mar 6. Epub 1969 Dec 31. PMID: 24642384. Abstract
Editors' Pick Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis. Bible E Nat Rev Neurol. 2014 Apr; 10(4):182. Epub 2014 Mar 18. PMID: 24638130. Abstract
Atypical MRI features at early onset natalizumab-associated progressive multifocal leukoencephalopathy: A case report. Piola M, Di Palma F, Mascoli N, Binda S, Arnaboldi M, Rezzonico M J Neurol Sci. 2014 Mar 5. PMID: 24642511. Abstract
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs. Lu E, Zhu F, Zhao Y, van der Kop M, Synnes A, Dahlgren L, Sadovnick DA, Traboulsee A, Tremlett H CNS Drugs. 2014 Mar 19. PMID: 24643915. Abstract
Significant increase in the prevalence of multiple sclerosis in iran in 2011. Izadi S, Nikseresht A, Sharifian M, Sahraian M A, Hamidian Jahromi A, Aghighi M, Heidary A Iran J Med Sci. 2014 Mar; 39(2):152-3. PMID: 24644387. Abstract
Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches. Guo S, Pelligra C, Saint-Laurent Thibault C, Hernandez L, Kansal A Pharmacoeconomics. 2014 Mar 19. PMID: 24643323. Abstract
miR-17-92 cluster targets Phosphatase and Tensin Homology and Ikaros Family Zinc Finger 4 to promote TH17-mediated inflammation. Liu S-Q, Jiang S, Li C, Zhang B, Li Q-J J Biol Chem. 2014 Mar 18. PMID: 24644282. Abstract
Participation of interleukin 17A in neuroimmune interactions. Moynes DM, Vanner SJ, Lomax AE Brain Behav Immun. 2014 Mar 15. PMID: 24642072. Abstract
Regulation of Experimental Autoimmune Encephalomyelitis by TPL-2 Kinase. Sriskantharajah S, Gückel E, Tsakiri N, Kierdorf K, Brender C, Ben-Addi A, Veldhoen M, Tsichlis PN, Stockinger B, O'Garra A, et al. J Immunol. 2014 Mar 17. PMID: 24639351. Abstract
Empyema presenting as lower extremity weakness. Saha D, Cepeda J, Hayden D, Ciment A Chest. 2014 Mar 1; 145(3 Suppl):118A. PMID: 24638293. Abstract
Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis. Chuluundorj D, Harding SA, Abernethy D, La Flamme A C Immunol Cell Biol. 2014 Mar 18. PMID: 24638064. Abstract
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method. Michel P, Baumstarck K, Boyer L, Fernandez O, Flachenecker P, Pelletier J, Loundou A, Ghattas B, Auquier P, on behalf of the MusiQoL Study Group Med Care. 2014 Mar 15. PMID: 24638117. Abstract
Targeting IL-10 in Auto-immune Diseases. Tian G, Li J-L, Wang D-G, Zhou D Cell Biochem Biophys. 2014 Mar 18. PMID: 24639111. Abstract
Review: In relapsing-remitting multiple sclerosis, disease-modifying agents reduce annual relapse rates. Weinshenker BG Ann Intern Med. 2014 Mar 18; 160(6):JC5. PMID: 24638183. Abstract
Core outcome measures for exercise studies in people with multiple sclerosis: recommendations from a multidisciplinary consensus meeting. Paul L, Coote S, Crosbie J, Dixon D, Hale L, Holloway E, McCrone P, Miller L, Saxton J, Sincock C, et al. Mult Scler. 2014 Mar 17. PMID: 24639480. Abstract
Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis. Sati P, Thomasson D, Li N, Pham D, Biassou N, Reich DS, Butman J Mult Scler. 2014 Mar 17. PMID: 24639479. Abstract
Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis. Narayanan D, Cheng H, Bonem KN, Saenz R, Tang RA, Frishman LJ Mult Scler. 2014 Mar 17. PMID: 24639478. Abstract
Transverse Myelitis Associated With an Itchy Rash and HyperCkemia: Neuromyelitis Optica Associated With Dermatitis Herpetiformis. Iyer A, Rathnasabapathi D, Elsone L, Mutch K, Terlizzo M, Footitt D, Jacob A JAMA Neurol. 2014 Mar 17. PMID: 24637913. Abstract
Human immunoglobulin G reduces the pathogenicity of aquaporin-4 autoantibodies in neuromyelitis optica. Ratelade J, Smith AJ, Verkman AS Exp Neurol. 2014 Mar 14; 255C:145-153. PMID: 24636863. Abstract
Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients. Gresle MM, Liu Y, Dagley LF, Haartsen J, Pearson F, Purcell AW, Laverick L, Petzold A, Lucas R, Van der Walt A, et al. J Neurol Neurosurg Psychiatry. 2014 Mar 17. PMID: 24639436. Abstract
Role of SFB in autoimmune arthritis: An example of regulation of autoreactive T cell sensitivity in the gut. Chappert P Gut Microbes. 2014 Feb 6; 5(2). PMID: 24637598. Abstract
Diffusion tensor imaging of the cervical spinal cord of patients with Neuromyelitis Optica. Rivero RLM, Oliveira EML, Bichuetti DB, Gabbai AA, Nogueira RG, Abdala N Magn Reson Imaging. 2014 Feb 7. PMID: 24636569. Abstract
[Immunomodulatory properties of stem mesenchymal cells in autoimmune diseases.] Sánchez-Berná I, Santiago-Díaz C, Jiménez-Alonso J Med Clin (Barc). 2014 Mar 14. PMID: 24636281. Abstract
Multiple sclerosis: TOWER confirms the efficacy of oral teriflunomide in MS. Haghikia A, Gold R Nat Rev Neurol. 2014 Apr; 10(4):183-4. Epub 2014 Mar 18. PMID: 24638132. Abstract
Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Friese MA, Schattling B, Fugger L Nat Rev Neurol. 2014 Apr; 10(4):225-38. Epub 2014 Mar 18. PMID: 24638138. Abstract
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis. Lill CM, Schilling M, Ansaloni S, Schröder J, Jaedicke M, Luessi F, Schjeide B-MM, Mashychev A, Graetz C, Akkad DA, et al. Neurogenetics. 2014 Mar 18. Epub 2014 Mar 18. PMID: 24638856. Abstract
Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants. Briggs FBS, Acuna B, Shen L, Ramsay P, Quach H, Bernstein A, Bellesis KH, Kockum IS, Hedström AK, Alfredsson L, et al. Epidemiology. 2014 Mar 12. PMID: 24625537. Abstract
Thermal and motor behavior in experimental autoimmune encephalitis in Lewis rats. Wrotek S, Rosochowicz T, Nowakowska A, Kozak W Autoimmunity. 2014 Mar 13. PMID: 24625014. Abstract
Regulatory T-cell vaccination independent of auto-antigen. Pascual DW, Yang X, Holderness K, Jun S, Maddaloni M, Kochetkova I Exp Mol Med. 2014; 46:e82. PMID: 24626168. Abstract
Optical coherence tomography shows retinal abnormalities associated with optic nerve disease. Tawse KL, Hedges TR, Gobuty M, Mendoza-Santiesteban C Br J Ophthalmol. 2014 Mar 13. PMID: 24627251. Abstract
DARC shuttles inflammatory chemokines across the blood-brain barrier during autoimmune central nervous system inflammation. Minten C, Alt C, Gentner M, Frei E, Deutsch U, Lyck R, Schaeren-Wiemers N, Rot A, Engelhardt B Brain. 2014 Mar 12. PMID: 24625696. Abstract
Aquaporins: important but elusive drug targets. Verkman AS, Anderson MO, Papadopoulos MC Nat Rev Drug Discov. 2014 Mar 14. PMID: 24625825. Abstract
Immunomodulatory agents and risk of postpartum multiple sclerosis relapses. Beaber B E, Chi MD, Brara S M, Zhang J L, Langer-Gould AM Perm J. 2014 Winter; 18(1):9-13. PMID: 24626066. Abstract
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study. Zivadinov R, Dwyer MG, Markovic-Plese S, Kennedy C, Bergsland N, Ramasamy DP, Durfee J, Hojnacki D, Hayward B, Dangond F, et al. PLoS One. 2014; 9(3):e91098. Epub 2014 Mar 13. PMID: 24625687. Abstract
Therapy optimization in multiple sclerosis: a prospective observational study of therapy compliance and outcomes. Coyle PK, Cohen BA, Leist T, Markowitz C, Oleen-Burkey M, Schwartz M, Tullman MJ, Zwibel H BMC Neurol. 2014; 14(1):49. Epub 2014 Mar 13. PMID: 24624979. Abstract
The Biological Functions, Structure and Sources of CXCL10 and Its Outstanding Part in the Pathophysiology of Multiple Sclerosis. Vazirinejad R, Ahmadi Z, Arababadi M K, Hassanshahi G, Kennedy D Neuroimmunomodulation. 2014 Mar 8. Epub 2014 Mar 08. PMID: 24642726. Abstract
Antineutrophil Cytoplasmic Antibodies in Patients with Idiopathic Inflammatory-Demyelinating Diseases. Long Y, Zheng Y, Chen M, Zhang B, Gao C, Gao Q, Yin J-R, Pu S, Xie C Neuroimmunomodulation. 2014 Mar 8. Epub 2014 Mar 08. PMID: 24642629. Abstract
Chemokines and chemokine receptors in multiple sclerosis. Cheng W, Chen G Mediators Inflamm. 2014; 2014:659206. Epub 2014 Jan 02. PMID: 24639600. Abstract